US medical group improves chronic disease risk prediction by 37%

37% better risk prediction

Chronic disease accuracy improved

3-week program

Focused clinical validation

14 primary care experts

Specialists mobilized

About our client

A US-based multi-specialty medical group with 320 primary care providers across 45 clinics, managing over 850,000 patient lives under value-based contracts. The group oversees 1.8 million annual encounters, with 65% focused on chronic disease management.

Industry
Healthcare - Primary care & population health
Share

Objective

The group wanted to strengthen their AI-powered platform for chronic disease management. Their goals were to predict disease progression more accurately, spot high-risk patients earlier, and personalize interventions tailored to individual needs. Success was measured by higher quality scores, fewer readmissions, and better financial performance under value-based contracts.

The challenge

Despite managing a large patient population, the group struggled to turn data into actionable insights:

  • Poor prediction accuracy: Existing models predicted only 38% of patients likely to face complications within 90 days
  • Missing social factors: Social determinants of health (SDOH) such as food and housing insecurity were ignored
  • Medication blind spots: False negatives were common in medication adherence detection
  • Generic interventions: Intervention recommendations lacked clinical specificity
  • Preventive care gaps: Preventive care gaps went undetected in more than 50% of cases
  • Financial impact: These gaps cost the group $5.1M annually in avoidable hospitalizations

Existing risk prediction tools couldn't capture the complexity of chronic disease progression or integrate social determinants effectively. The group needed a clinically grounded approach that could identify high-risk patients earlier and recommend personalized interventions.

CleverX solution

We partnered with the group to build a clinically grounded risk prediction model enhanced by expert training and rigorous validation.

Expert recruitment:

  • 14 primary care experts including family physicians, internists, and care coordinators
  • Covered key conditions: diabetes, hypertension, COPD
  • Deep knowledge of Medicare Advantage, ACOs, and value-based reporting

Technical framework:

  • Built multi-condition models to capture comorbidity interactions
  • Created 24-month longitudinal datasets tracking patient trajectories
  • Integrated Z-codes and community-level SDOH indicators
  • Personalized intervention logic using patient activation scores

Quality protocols:

  • Weekly clinical review boards for continuous feedback
  • Validation with both claims and EHR datasets
  • Applied rolling 90-day recalibration windows
  • Documented all recommendations with transparent clinical rationale

Impact

Within just 12 weeks, the medical group had fully recalibrated its risk prediction engine and deployed targeted care interventions:

  • Five years of historical patient data and 18,000 annotated patient journeys enriched model training
  • The system surfaced non-traditional risk factors like housing instability
  • Interventions became faster, more targeted, and clinically relevant
  • Preventive care compliance improved while hospitalizations decreased
  • The AI models were integrated into Epic, Cerner, and Athena EHRs, supporting 250,000+ patient-years of risk management

The program transformed how the medical group approached population health management, creating a sophisticated risk prediction framework that could adapt to changing patient needs while maintaining high clinical standards.

Result

The chronic disease risk prediction program delivered comprehensive improvements across efficiency, quality, and financial performance:

Efficiency gains:

42% reduction in case review time, preventive care detection cut from 45 days to 12 days, 38% boost in preventive completions through automated reminders, and HEDIS reporting timelines improved by 3 weeks per quarter.

Quality improvements:

37% increase in 90-day readmission prediction accuracy (AUC 0.68 to 0.87), medication adherence detection improved from 39% to 76%, care gap closure improved from 48% to 71%, and 29% improvement in diabetes control among pilot patients.

Business impact:

$2.3M recovered in performance bonuses, 31% reduction in preventable hospitalizations, $3.7M saved in shared savings penalties, and quality ratings improved from 3.5 to 4.2 stars.

Strategic wins:

Built proprietary AI model spanning 250,000+ patient-years, improved RAF scores by 8% through accurate risk adjustment, developed plug-and-play workflows for major EHRs, and recognized with the AMGA Acclaim Award for population health innovation.

Discover how CleverX can streamline your B2B research needs

Book a free demo today!

Trusted by participants